|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 209/10 | (2006.01) |
| A61P 1/00 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2046740 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07766323.5 |
| Date of filing the European patent application | 2007-07-20 | |
| (97) | Date of publication of the European application | 2009-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2012-05-23 |
| (46) | Date of publication of the claims translation | 2012-10-25 |
| (86) | Number | PCT/GB2007/002761 |
| Date | 2007-07-20 |
| (87) | Number | WO 2008/012511 |
| Date | 2008-01-31 |
| (30) | Number | Date | Country code |
| 0614608 | 2006-07-22 | GB | |
| 0624176 | 2006-12-04 | GB |
| (72) |
ARMER, Richard, Edward, GB
WYNNE, Graham, Michael, GB
DORGAN, Colin, Richard, GB
JOHNSON, Peter, David, GB
|
| (73) |
Atopix Therapeutics Limited,
265 Strand, London WC2R 1BH,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Junginiai, pasižymintys CRTH2 antagonistiniu aktyvumu |
| COMPOUNDS HAVING CRTH2 ANTAGONIST ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2013-06-19 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-07-20 |